Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152,309,909
-
Total 13F shares
-
158,628,992
-
Share change
-
-1,874,335
-
Total reported value
-
$8,162,083,726
-
Put/Call ratio
-
36%
-
Price per share
-
$51.45
-
Number of holders
-
549
-
Value change
-
-$121,661,613
-
Number of buys
-
295
-
Number of sells
-
292
Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q2 2025
As of 30 Jun 2025,
BIO-TECHNE Corp - COMMON STOCK (TECH) was held by
549 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,628,992 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, MORGAN STANLEY, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., AMERIPRISE FINANCIAL INC, Select Equity Group, L.P., and BAMCO INC /NY/.
This page lists
550
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.